Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms

Journal of Pediatric Gastroenterology and Nutrition

Volumn 48, Issue 2, 2009, Pages 168-174

  Pfefferkorn, Marian ^a,r   Burke, Georgine ^b   Griffiths, Anne ^c   Markowitz, James ^d   Rosh, Joel ^e   MacK, David ^f   Otley, Anthony ^g   Kugathasan, Subra ^h   Evans, Jonathan ⁱ   Bousvaros, Athos ^j   Moyer, M Susan ^k   Wyllie, Robert ^l   Oliva Hemker, Maria ^m   Carvalho, Ryan ⁿ   Crandall, Wallace ^o   Keljo, David ^p   Walters, T D ^c   Leleiko, Neal ^q   Hyams, Jeffrey ^b  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b Farmington   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d North Shore Long Island Jewish Health System ^*  (United States)

^e Atlantic Health   (United States)

^f CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^g IWK HEALTH CENTRE   (Canada)

^h CHILDREN S HOSPITAL OF WISCONSIN   (United States)

ⁱ NEMOURS CHILDREN S CLINIC   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m JOHNS HOPKINS HOSPITAL   (United States)

ⁿ CHILDREN S MEDICAL CENTER   (United States)

^o NATIONWIDE CHILDREN S HOSPITAL   (United States)

^p CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^q HASBRO CHILDREN'S HOSPITAL   (United States)

^r INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Crohn disease; Growth; Pediatric inflammatory bowel disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ARTICLE; BODY HEIGHT; CHILD; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; GROWTH DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; ADOLESCENT; CONFIDENCE INTERVAL; DRUG EFFECT; GROWTH; HOSPITALIZATION; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RISK; SEXUAL MATURATION; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BODY HEIGHT; CHILD; COHORT STUDIES; CONFIDENCE INTERVALS; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; GROWTH; GROWTH DISORDERS; HUMANS; MALE; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEXUAL MATURATION; TREATMENT OUTCOME;

EID: 66149092740     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318175ca7f     Document Type: Article

References (24)

1. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988;95:1523-7.
2. Kirschner BS. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand Suppl 1990;366:98-104.
3. Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-43.
4. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18:165-73.
5. Sawczenko A, Ballinger AB, Savage MO, et al. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease. Pediatrics 2006;118:124-9.
6. Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993; 16:373-80.
7. Sawczenko A, Ballinger AB, Croft NM, et al. Adult height in patients with early onset of Crohn's disease. Gut 2003;52: 454-5.
8. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-91.
9. Hyams JS, Moore RE, Leichtner AM, et al. Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease. J Pediatr 1988;112:893-8.
10. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002;58 (Suppl 1):7-10.
11. Sawczenko A, Azooz O, Paraszczuk J, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A 2005;102:13260-5.
12. DiFedele LM, He J, Bonkowski EL, et al. Tumor necrosis factor a blockade restores growth hormone signaling in murine colitis. Gastroenterology 2005;128:1278-91.
13. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
14. Tanner JM, Davies PSW. Clinical longitudinal standards for height velocity for North American children. J Pediatr 1985;107:317-29.
15. Zoli G, Katelaris PH, Garrow J, et al. Increased energy expenditure in growing adolescents with Crohn disease. Dig Dis Sci 1996; 41:1754-9.
16. Ballinger AB, Azooz A, El-Haj T, et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is indepen- dentofundernutritioninarat modelofcolitis.Gut2000;46:694-700.
17. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167:1211-27.
18. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
19. Walters T, Gilman A, Griffiths A. Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis 2007;13:424-30.
20. McHugh KJ, Collins SM, Weingarten HP. Central interleukin-1 receptors contribute to suppression of feeding after acute colitis in the rat. Am J Physiol 1994;266 (5 Pt 2):R1659-63.
21. Levine A, Shamir R, Wine E, et al. TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease. Am J Gastroenterol 2005;100:1598-604.
22. Wine E, Reif SS, Leshinsky-Silver E, et al. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics 2004;114:1281-6.
23. Russell RK, Drummond HE, Nimmo EE, et al. Genotype-pheno-type analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis 2005;11:955-64.
24. Russell RK, Drummond HE, Nimmo ER, et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut 2006;55:1114-23.